Skip to main content

Monopar Therapeutics

MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001645469

In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 7 sales; 105 institutions reported holding it in 13F filings for Q3 2026, worth $495.1M in total; no superinvestor holds it.

Holders of 5% or more of MNPR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Monopar Therapeutics, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MNPR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Janus Henderson Group PLC13G/A16.70%1.12M shares−2.80 ppfrom 19.50%Nov 6, 20246 filingsNov 16, 2026SEC
Ra Capital Management, L.P.13G/A9.90%667.6K shares0.00 ppfrom 9.90%Oct 31, 20244 filingsFeb 17, 2026SEC
AstraZeneca PLC13G/A7.80%522.7K shares–Oct 28, 20242 filingsFeb 6, 2026SEC
BlackRock, Inc.13G5.03%338.1K sharesNewOct 27, 20261 filingOct 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

24 Schedule 13D and 13G filings on Monopar Therapeutics, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MNPR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 16, 202612:24 PM ETJanus Henderson Group PLC13G/A16.70%1.12M shares−2.80 ppfrom 19.50%Sep 30, 2026SEC
Oct 27, 20265:25 PM ETBlackRock, Inc.13G5.03%338.1K sharesNewSep 30, 2026SEC
Aug 12, 20266:26 PM ETSaturn V Capital Management LLCand 1 other13G/A4.70%313.4K shares−0.50 ppfrom 5.20%Below 5%Jun 30, 2026SEC
Aug 12, 202612:05 PM ETAdage Capital Management, L.P.and 2 others13G/A4.76%324.2K shares−1.47 ppfrom 6.23%Below 5%Jun 30, 2026SEC
May 15, 20261:26 PM ETSaturn V Capital Management LLCand 1 other13G5.20%345.6K sharesNewJan 5, 2026SEC
May 13, 20269:10 AM ETAdage Capital Management, L.P.and 2 others13G/A6.23%424.2K shares−3.63 ppfrom 9.86%Mar 31, 2026SEC
Feb 17, 20264:37 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%667.6K shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Feb 6, 20269:54 AM ETAstraZeneca PLCand 1 other13G/A7.80%522.7K shares–Dec 31, 2025SEC
Jan 30, 20262:32 PM ETTactic Pharma LLCand 2 others13D/A4.50%307.4K shares−3.00 ppfrom 7.50%Below 5%Jan 28, 2026SEC
Nov 14, 20254:16 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%742.9K shares0.00 ppfrom 9.90%Sep 30, 2025SEC
Nov 14, 202512:49 PM ETJanus Henderson Group PLCand 1 other13G/A19.50%1.29M shares+0.30 ppfrom 19.20%Sep 30, 2025SEC
Sep 24, 20258:59 PM ETTactic Pharma LLCand 4 others13D/A7.50%506.2K shares–Sep 24, 2025SEC
Aug 14, 202510:58 AM ETJanus Henderson Group PLCand 1 other13G/A19.20%1.17M shares+0.60 ppfrom 18.60%Jun 30, 2025SEC
May 14, 202511:59 AM ETJanus Henderson Group PLCand 1 other13G/A18.60%1.13M shares+1.40 ppfrom 17.20%Mar 31, 2025SEC
Feb 14, 20256:25 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%620.1K shares–Dec 31, 2024SEC
Feb 14, 20254:00 PM ETTang Capital Management LLCand 4 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 12, 20259:45 AM ETAdage Capital Management, L.P.and 2 others13G9.86%599.2K sharesNewDec 31, 2024SEC
Jan 8, 202511:38 AM ETJanus Henderson Group PLCand 1 other13G/A17.20%1.05M shares–Dec 31, 2024SEC
Dec 17, 2024Tactic Pharma LLC13D/AOld format–––SEC
Nov 6, 2024Janus Henderson Group PLC13GOld format–New–SEC
Oct 31, 2024Ra Capital Management, L.P.13GOld format–New–SEC
Oct 28, 20246:00 AM ETAstraZeneca PLC13GOld format–New–SEC
Oct 24, 2024Tang Capital Management LLC13GOld format–New–SEC
Jun 2, 2023Klunzinger Jeffrey R.13GOld format–New–SEC

Form 144: proposed insider sales

11 notices from officers, directors and other affiliates planning to sell Monopar Therapeutics shares, newest first.

Form 144 notices for MNPR
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Oct 1, 20264:37 PM ETChristopher StarrDirector16.8K$1.34MOct 1, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Sep 24, 20264:40 PM ETChandler RobinsonDirector · Officer29.1K$2.60MSep 24, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 26, 20264:19 PM ETPatrice RiouxActing Chief Medical Officer1$110.82Aug 26, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 26, 20264:18 PM ETKim TsuchimotoDirector8.18K$906.5KAug 26, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 25, 20264:44 PM ETRaymond William AndersonDirector6.28K$699.8KAug 25, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jul 10, 20266:01 PM ETAmendedArthur KlausnerFormer Board Member5.00K$477.0KJul 8, 2026MLPFSSEC
Dec 19, 20254:00 PM ETArthur KlausnerBoard Member5.12K$343.9KDec 18, 2025MLPFSSEC
Jul 14, 202512:29 PM ETStarr Christopher MDirector16.8K$672.0KJul 14, 2025Merrill Lynch Pierce Fenner & Smith Inc.SEC
Jul 14, 202512:26 PM ETTsuchimoto Kim RDirector8.90K$356.2KJul 14, 2025Merrill Lynch Pierce Fenner & Smith Inc.SEC
Jul 14, 202512:21 PM ETRobinson ChandlerOfficer · Director16.8K$672.0KJul 14, 2025Merrill Lynch Pierce Fenner & Smith Inc.SEC
Apr 2, 202511:45 AM ETTactic Pharma LLC10% stockholder33.3K$1.17MApr 2, 2025Merrill Lynch, Pierce, Fenner & Smith, Inc.SEC